BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND DEK, D6S231E, 7913, ENSG00000124795, P35659 AND Prognosis
5 results:

  • 1. p21-activated kinase 2 binds to transcription factor SOX2 and up-regulates dek to promote the progression of lung squamous cell carcinoma.
    Xie S; Wan X; Chen S; Hu Y; Liu X
    Lab Invest; 2022 Oct; 102(10):1109-1120. PubMed ID: 35821094
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. dek promotes the proliferation and invasion of lung cancers and indicates poor prognosis in lung adenocarcinomas.
    Yang MQ; Bai LL; Lei L; Zheng YW; Wang Z; Li ZH; Liu CC; Huang WJ; Xu HT
    Oncol Rep; 2020 Apr; 43(4):1338-1348. PubMed ID: 32020224
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. High expression of oncoprotein dek predicts poor prognosis of small cell lung cancer.
    Wang X; Lin L; Ren X; Lin Z; Li Z; Li C; Jin T
    Int J Clin Exp Pathol; 2014; 7(8):5016-23. PubMed ID: 25197373
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. dek expression in Merkel cell carcinoma and small cell carcinoma.
    Patel RM; Walters LL; Kappes F; Mehra R; Fullen DR; Markovitz DM; Ma L
    J Cutan Pathol; 2012 Aug; 39(8):753-7. PubMed ID: 22765016
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. dek oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung.
    Shibata T; Kokubu A; Miyamoto M; Hosoda F; Gotoh M; Tsuta K; Asamura H; Matsuno Y; Kondo T; Imoto I; Inazawa J; Hirohashi S
    Oncogene; 2010 Aug; 29(33):4671-81. PubMed ID: 20543864
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.